Do you want to link to our other external sites and leave Amgen.ca?


You are now leaving the Amgen Canada website. Please note that the information you are about to view may not comply with Canadian regulatory requirements. Marketing authorizations and availability of products may differ between Canada and other countries.

Do you want to link to the external site and leave Amgen.ca?


You are now leaving the Amgen Canada website. Please note that the information you are about to view may not comply with Canadian regulatory requirements. Marketing authorizations and availability of products may differ between Canada and other countries.

Understanding Life. Transforming Medicine.

Some of the greatest advances in science are taking place now inside Amgen. Watch and hear the stories from the scientists making it happen.

LEARN MORE

For more than a decade, Amgen scientists have applied innovative research to advance important new therapies for grievous illnesses. Amgen’s heritage in cutting-edge molecular biology has led to the development of protein therapeutics that have transformed the management of anemia, inflammation and cancer.

More recently, Amgen has assembled a multidisciplinary group of chemists and biologists who together approach the challenge of drug discovery using multiple potential therapeutic modalities. This approach allows us to choose the best target for attacking a disease and to use the modality most likely to affect that target. The research program has yielded a heightened understanding of human disease, and innovative new approaches to improving human health.

Our Research and Development (R&D) engine is powered by dedicated, creative scientists who are attracted to Amgen by our intellectual vigor, our commitment to world-class research and most importantly, by the many opportunities we offer to make a dramatic difference in the lives of patients.

In This Section

Pipelineicon

Amgen has created a robust and differentiated pipeline, leveraging state-of-the-art science to create medicines for serious illnesses.

Clinical Trialsicon

Among the most important steps in the long and careful process to develop new therapies are clinical trials, where people volunteer to receive an experimental new drug or procedure and be observed for its effects.

Research and Development Strategyicon

Amgen has built an organization distinguished by world-class scientists with a talent for applying novel approaches to treat disease. Our R&D strategy aims to align and engage our talent, prioritize investments, and seize scientific opportunities.

An Introduction to Biotechnologyicon

Biotechnology has brought about the discovery and development of a new generation of human therapeutics. Advancements in both cellular and molecular biology have allowed scientists to identify and develop a host of new cost-effective products.

Manufacturingicon

At Amgen, we continually invest in our manufacturing to strengthen our industry-leading capabilities and extend our global reach. Our commitment is to ensure that all our medicines are available for "every patient, every time."

Biosimilarsicon

Biosimilars offer the potential to increase patient access to vital medicines. Amgen is well positioned to leverage its more than 35 years of experience in biotechnology to create high-quality biosimilars and reliably supply them to patients worldwide.

DOWNLOADS

Amgen Fact Sheet

Amgen Canada Fact Sheet

Amgen BC Fact Sheet